<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05070026</url>
  </required_header>
  <id_info>
    <org_study_id>uni-portal and three port VATS</org_study_id>
    <nct_id>NCT05070026</nct_id>
  </id_info>
  <brief_title>Differences Between of Uni-portal and Three Port Video-assisted Thoracoscopic Surgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung Cancer</brief_title>
  <official_title>Differences Between of Uni-portal and Three Port Video-assisted Thoracoscopic Surgery on Perioperative Outcomes and Quality of Life Scores of Patients With Non-small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shengjing Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the last fifteen years, the investigator have seen a substantial change of course in&#xD;
      the scenario of thoracic surgery. The minimally invasive video-assisted surgical approach has&#xD;
      spread in a gradually wider and more rapid way, being nowadays the treatment of choice for&#xD;
      many thoracic disease traditionally managed by open surgery. The study is to observe and&#xD;
      compare the effects of two kinds of pulmonary lobectomy on perioperative clinical&#xD;
      indexes、inflammatory reaction and quality of life scores of patients with non-small cell lung&#xD;
      cancer&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative hemorrhage volume</measure>
    <time_frame>at the end of the surgery</time_frame>
    <description>record intraoperative hemorrhage volume at the end of the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>chest drainage time</measure>
    <time_frame>before remove drainage tube</time_frame>
    <description>record chest drainage time until remove drainage tube</description>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of the healing of incision</measure>
    <time_frame>before suture removal</time_frame>
    <description>record the duration of the healing of incision</description>
  </primary_outcome>
  <primary_outcome>
    <measure>out-of-bed activity time (Day) and length of hospital stay (Day)</measure>
    <time_frame>Before discharge from hospital</time_frame>
    <description>record the days of patients' out-of-bed activity time and length of hospital stay after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>record postoperative pain 24 hours after surgery by using visual analog scale (VAS) score, where 0 indicates painlessness, and 10 indicates severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative adverse effects</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>record postoperative adverse effects 24 hours after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative inflammation</measure>
    <time_frame>Day 1 after operation</time_frame>
    <description>record c-reactive protein after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative inflammation</measure>
    <time_frame>Day 4 after operation</time_frame>
    <description>record c-reactive protein after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative inflammation</measure>
    <time_frame>Day 7 after operation</time_frame>
    <description>record c-reactive protein after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Video-assisted Thoracoscopic Surgery</condition>
  <condition>Inflammatory Reaction</condition>
  <condition>Life Scores</condition>
  <arm_group>
    <arm_group_label>uni-portal VATS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>three port VATS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>uni-portal VATS group</intervention_name>
    <description>patients received pulmonary lobectomy under general anesthesia by using uni-portal VATS method</description>
    <arm_group_label>uni-portal VATS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>three port VATS group</intervention_name>
    <description>patients received pulmonary lobectomy under under general anesthesia by using three port VATS method</description>
    <arm_group_label>three port VATS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with American Society of Anesthesiologists (ASA) grade I-II;&#xD;
&#xD;
          -  patients with a body mass index (BMI) of 18 to 25 kg/m2;&#xD;
&#xD;
          -  age between 18 to 75 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with central nervous system and mental diseases;&#xD;
&#xD;
          -  patients with a medication history use of sedative, analgesic or antidepression drugs&#xD;
&#xD;
          -  patients with sinus bradycardia or atrioventricular block grade II or greater;&#xD;
&#xD;
          -  patients with severe visual or hearing impairment or who were unable to communicate.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>junchao zhu</last_name>
    <phone>+8618940257257</phone>
    <email>zhujunchao1@hotmail.com</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 12, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shengjing Hospital</investigator_affiliation>
    <investigator_full_name>Yanchao Yang</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

